PTSD and Predictors of Residential Drug Treatment Drop Out

Information

  • Research Project
  • 7664701
  • ApplicationId
    7664701
  • Core Project Number
    R21DA022383
  • Full Project Number
    7R21DA022383-02
  • Serial Number
    22383
  • FOA Number
    PA-06-81
  • Sub Project Id
  • Project Start Date
    4/1/2008 - 16 years ago
  • Project End Date
    3/31/2010 - 14 years ago
  • Program Officer Name
    KAHANA, SHOSHANA Y
  • Budget Start Date
    7/1/2008 - 16 years ago
  • Budget End Date
    3/31/2009 - 15 years ago
  • Fiscal Year
    2008
  • Support Year
    2
  • Suffix
  • Award Notice Date
    8/22/2008 - 16 years ago

PTSD and Predictors of Residential Drug Treatment Drop Out

[unreadable] DESCRIPTION (provided by applicant): Substance use disorders (SUDs) are highly comorbid with posttraumatic stress disorder (PTSD; Kessler et al., 1995), and this particular comorbidity is associated with a greater likelihood of substance use treatment failure (e.g., Ouimette et al., 1998). Further, research suggests that it is not traumatic exposure per se that puts substance users at greater risk for treatment failure, but whether or not PTSD is present (Chilcoat & Breslau, 1998). Despite some evidence that there is something unique to the presence of PTSD that negatively affects the course and outcome of substance use treatment, studies have not yet comprehensively examined whether this heightened risk is due to current PTSD, past PTSD, or simply a consequence of severe past traumatic exposure. Further, studies have yet to explore the specific mechanisms underlying this increased risk. Mechanisms may be identified from the self-medication model of substance use (Brady et al., 2004). Building from this model, SUD patients with current PTSD may be at risk for treatment drop-out to the extent to which they exhibit emotional vulnerabilities in the form of (a) emotion deregulation; (b) anxiety sensitivity; (c) distress intolerance; (d) emotional avoidance; and/or e) HPA axis dysfunction. To test the mediational role of these variables in treatment drop-out, we will examine four groups (n = 50/group) of inner-city drug users in a residential treatment center: (1) SUD patients with no history of DSM-IV PTSD criterion A traumatic exposure; (2) SUD patients with a history of DSM-IV PTSD criterion A traumatic exposure but not meeting criteria for current or past PTSD; (3) SUD patients with a history of DSM-IV PTSD criterion A traumatic exposure not meeting criteria for current PTSD (past month), but meeting criteria for past PTSD (criteria met for a PTSD diagnosis before one month ago); and (4) SUD patients meeting criteria for current PTSD (which includes the presence of criterion A traumatic exposure). We expect that SUD patients with current PTSD, as compared to all other groups, will exhibit the highest rates of treatment drop-out. Further, emotion dysregulation, anxiety sensitivity, emotional avoidance, low distress tolerance, and HPA axis dysfunction will mediate this relationship, even when controlling for variables often associated with treatment failure (e.g., demographics, negative affect, treatment readiness, severity of past traumatic exposure, level of drug dependence, psychiatric comorbidity). [unreadable] [unreadable] [unreadable]

IC Name
NATIONAL INSTITUTE ON DRUG ABUSE
  • Activity
    R21
  • Administering IC
    DA
  • Application Type
    7
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    189609
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    279
  • Ed Inst. Type
    SCHOOLS OF MEDICINE
  • Funding ICs
    NIDA:189609\
  • Funding Mechanism
  • Study Section
    NIDA
  • Study Section Name
    Neuropharmacology Research Subcommittee
  • Organization Name
    UNIVERSITY OF MISSISSIPPI MEDICAL CENTER
  • Organization Department
    PSYCHIATRY
  • Organization DUNS
    928824473
  • Organization City
    JACKSON
  • Organization State
    MS
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    39216
  • Organization District
    UNITED STATES